Pallas Health NAD+ Nasal Spray vs. Injection: Could This Be the At-Home NAD+ Option You've Been Looking For? Compare the Daily Spray and Weekly Injection

NEWARK, Del., August 15, 2026 (Newswire.com) - Quick disclosure before you read further: this is a paid advertorial, intended for consumer education about a commercially available product. Where this article uses the word "Investigated," it means this article's own sponsored publishers editorial review of public brand materials - not any external regulatory or legal action. A commission is earned if you purchase through links here. Product claims are attributed to the brand and not independently endorsed. Pallas Health's NAD+ program is prescription medication, available only after evaluation and approval by a licensed healthcare provider if clinically appropriate - approval isn't guaranteed, and the compounded medications discussed are not FDA-approved and haven't been evaluated by the FDA for safety, effectiveness, or quality. Official site: pallashealth.co/lp/nad. Details reflect brand materials reviewed in August 2026 - confirm current information before ordering.

Pallas Health NAD+ Nasal Spray vs. Injection Investigated 2026: Pricing Reviews, Researches Process, and Which One Is Right for You (Consumer Research)

Here's the short version: Pallas Health connects you with Lion MD, an independent network of US-licensed clinicians, who decide - after reviewing your health history - whether prescription NAD+ makes sense for you. Pick a daily nasal spray or a weekly injection; if approved, one of several licensed US compounding pharmacies ships it to your door. First month starts at $79 for the spray or $89 for the injection, then averages $189-$199 a month, clinician and ongoing care included. Nothing ships unless a clinician actually prescribes it.

You saw an ad for Pallas Health's NAD+ program. Maybe it showed up on Instagram, maybe it was a short video about "healthy aging" or "everyday energy," maybe a friend mentioned it. Something caught your attention, and now you're doing exactly what smart buyers do before spending money on a prescription program: checking the details first. That's the right instinct, especially with a compounded, clinician-prescribed product - the kind of purchase where the fine print (who's actually writing the prescription, what pharmacy fills it, what happens if a clinician says no) matters a lot more than it does for a bottle of vitamins. So this article went and checked it: the pricing, the entities behind it, the physicians named on the clinical disclosures page, the fine print in the refund terms. And if you've already started comparing nasal spray against injection, you've probably noticed a lot of sites making confident claims about which one works "faster" or "better" without pointing to much to back it up. This article sticks to what's actually documented and says so plainly wherever the evidence runs thinner than the marketing.

View current Pallas Health NAD+ program details

What Is the Pallas Health NAD+ Program, and Who Is It For?

Pallas Health markets its NAD+ program to two overlapping groups: people chasing "everyday energy" and people interested in what the brand calls "healthy aging." According to the brand, NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, involved in converting food into cellular energy. Levels are described as tending to decline with age. That's a fair description of NAD+'s basic biology - it's a real, well-studied molecule. But "involved in energy metabolism" and "clinically shown to boost your energy" are two very different claims. This article sticks to the first one, because that's what's actually documented.

What makes this a telehealth product rather than a supplement is the delivery mechanism: this isn't a bottle you order and take on your own judgment. It's a prescription. A US-licensed clinician reviews your health history, current medications, and goals, and decides - using independent clinical judgment - whether NAD+ is appropriate for you, and if so, which form. The brand states plainly on its own FAQ that "research on supplemental NAD+ is still developing," and frames the clinician review as the reason a prescription-based model exists rather than an over-the-counter one. Worth taking that framing at face value, since it stops short of the aggressive anti-aging claims you'll find elsewhere in this category.

Basic eligibility, per the brand: you need to be 18 or older and located in a US state where the service is currently available (Pallas Health lists all 50 states plus Washington, D.C.). Beyond that, eligibility and treatment decisions rest with a US-licensed clinician - this article can describe the program's structure, but it can't tell you whether NAD+ is appropriate for your specific situation. What it can tell you is who this structure tends to fit: if you'd rather have a clinician actually look at your case than guess your own dosing from an unregulated bottle, and you're fine with a subscription instead of a one-time buy, that's exactly what this is built around. If you'd rather skip the clinician entirely and just order something off a shelf, this isn't that - and it isn't trying to be.

What Does "Clinician-Prescribed" Actually Mean at Pallas Health?

This is the section worth reading closely, because "clinician-prescribed" gets used loosely across the telehealth industry. Pallas Health's own clinical disclosures page lays out three separate organizations, and none of them is the same company:

• Pallas Health (the platform). A technology platform operated by Brentmoor, Inc. According to the brand's own clinical disclosures, Pallas does not employ medical providers, does not practice medicine, and does not direct clinical decisions. Its role is intake, scheduling, billing, and the patient-facing app - not prescribing.

• Lion MD (the medical group). Delivers clinical care as a nationwide team of US-licensed medical professionals operating through affiliated, state-licensed professional corporations, in partnership with a clinical-operations platform called CareValidate that Pallas says verifies provider licensure and manages clinical workflows. Every prescribing clinician is stated to hold an active, unrestricted license in the state where the patient is physically located at the time of the encounter, and clinicians are described as exercising independent clinical judgment - including the ability to decline to prescribe.

• The dispensing pharmacy (varies by order). Pallas Health does not own or operate a pharmacy. Prescriptions are filled by one of six named US-licensed partner pharmacies - Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, and Foothills Pharmacy - depending on the medication, shipping state, and current capacity.

Two named physicians make up Pallas Health's stated medical leadership: Dr. Ana Lisa Carr, MD, described as board-certified in family medicine, obesity medicine, and addiction medicine, with an NPI number (1689841744) that's independently checkable in the federal NPPES NPI Registry; and Dr. Kelly Tenbrink, MD, described as board-certified in emergency medicine, with NPI number 1346482684, also checkable in the same federal registry. This article notes both names and credentials as the brand presents them, alongside the independently verifiable NPI records - that combination (named claim plus a public registry link) is a meaningfully different situation from a brand naming an unverifiable "Dr." with no checkable credential anywhere.

The pharmacy side splits into two regulatory categories worth knowing: 503A compounding pharmacies, which are licensed and inspected by their respective state boards of pharmacy, and 503B outsourcing facilities, which are registered with and inspected by the FDA under current Good Manufacturing Practice standards. Registration with the FDA isn't the same thing as FDA approval of the compounded medication itself - nothing about a 503B facility's federal registration means the specific compounded NAD+ product has been evaluated or approved by the FDA for safety, effectiveness, or quality.

Put together: Pallas Health is the front door, Lion MD's clinicians make the actual prescribing decision, and one of six named pharmacies fills it if approved. No single entity here is playing more than one of those three roles, at least according to what the brand discloses.

What the Research Says About NAD+ (And What It Doesn't)

NAD+ is a real, extensively studied coenzyme - that part isn't in dispute anywhere in the scientific literature. Where things get more complicated is the specific question of whether boosting NAD+ levels in an otherwise healthy adult produces a noticeable benefit, and that's worth separating clearly from the general biology.

Peer-reviewed research on NAD+ has generally focused on two different things: the biology of NAD+ decline itself, and human trials of NAD+ precursor supplements - compounds like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), taken orally, that the body converts into NAD+. A 2025 paper by Vinten and colleagues in Nature Metabolism ("NAD+ precursor supplementation in human ageing: clinical evidence and challenges") notes that NAD+ decline has long been implicated in aging and age-related disorders. But the evidence for an age-related decline in NAD+ levels in humans specifically is still being clarified - the underlying premise is more contested in the human data than in animal models. A 2025 systematic review in the journal Geromedicine ("Clinical evidence for the use of NAD+ precursors to slow aging") searched PubMed for randomized controlled trials published between 2020 and 2025 involving NAD+ precursors and aging. It found most of that trial activity centered on oral precursor compounds - nicotinamide riboside, nicotinamide mononucleotide, niacin, nicotinic acid, and nicotinamide - rather than on direct NAD+ administration by injection or nasal spray, which is the delivery method Pallas Health prescribes.

One more data point worth flagging: a 2026 retrospective pilot study by Reyna and colleagues, published in Frontiers in Aging and indexed on PubMed Central, compared tolerability of intravenous NAD+ infusion against nicotinamide riboside in a real-world setting. It's a tolerability study, not an efficacy trial, and it looked at IV infusion specifically - not the subcutaneous injection or intranasal spray formats Pallas Health prescribes, and not a large randomized trial. It's the closest thing to direct-NAD+-administration research this article located, and it's a meaningfully different route and a meaningfully smaller evidence base than the oral precursor literature above.

None of this means NAD+ "doesn't work" or that Pallas Health is making claims it can't back up. Notably, the brand's own materials are unusually restrained here, describing NAD+'s role in energy metabolism and stating outright that research on supplementation is still developing, rather than promising specific outcomes. What it does mean is that the strongest research base right now sits at the level of general NAD+ biology and oral precursor trials, not at the level of a finished-product trial on Pallas Health's specific compounded nasal spray or injection. No clinical trial of Pallas Health's own formulation was identified in the sources reviewed for this article, and none is claimed by the brand.

See what Pallas Health NAD+ actually costs

Pallas Health NAD+ Side Effects and Safety: What's Actually Documented

This is worth addressing directly, because it's one of the first things people search before starting any prescription program. Pallas Health's public pages reviewed for this article don't publish a specific side-effect list for its compounded NAD+ nasal spray or injection. This article isn't going to invent one - extrapolating adverse-event data from a different product or a different route of administration would be more misleading than saying nothing at all.

What is documented: the 2026 retrospective tolerability pilot study referenced in the research section above (Reyna et al.) examined intravenous NAD+ infusion, not the subcutaneous injection or nasal spray Pallas Health prescribes - so its findings shouldn't be assumed to transfer directly to Pallas Health's formats. Beyond that, the safety review built into this program is the clinical intake itself: a licensed clinician reviews your medical history, current medications, and allergies before prescribing, and is described by the brand as able to decline to prescribe if it isn't appropriate. Questions about expected side effects for your specific formulation and health profile belong with that clinician, not with this article or with general internet research.

Nasal Spray or Injection: How the Choice Actually Works

Pallas Health offers two delivery formats for its prescribed NAD+. According to the brand, the choice is the patient's to make during intake, subject to a clinician confirming it's appropriate and personalizing the dosing:

The daily nasal spray is positioned as the no-needle option - something used once a day as part of a routine. The weekly subcutaneous injection is administered once a week rather than daily. The public NAD+ program page does not state the concentration or per-dose amount for either format. Final dosing is personalized by the treating clinician, according to Pallas Health. Buyers who want the precise formulation and dosing before starting should ask directly during the intake process or by contacting the brand at the addresses listed later in this article.

What's Included in the Pallas Health NAD+ Program

According to the checkout page reviewed for this article, both plans are priced as an all-in package rather than a bare medication cost. The brand states the price includes provider care, ongoing check-ins, and care-team messaging, with no separate membership fee layered on top.

The process, according to the brand's own description, runs in three steps:

1. Complete a roughly two-minute online health questionnaire covering medical history, current medications, allergies, vitals, and goals.

2. A licensed clinician reviews it and, in states that require it, conducts a live video visit before prescribing.

3. If approved, the prescription routes to one of the partner pharmacies and ships free and discreetly, with the brand citing roughly a one-week turnaround. Ongoing support continues afterward through asynchronous messaging, dose-adjustment visits, and follow-up evaluations - refills aren't automatic, and each renewal involves a clinician reviewing progress and tolerability rather than auto-shipping indefinitely.

A handful of states currently require a synchronous audio or video visit before the patient-provider relationship can be established, according to the brand's clinical disclosures page: Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, and Washington, D.C. In those states, checkout may collect a $60 visit deposit instead of the full first payment, which is credited toward the first order if a clinician approves the plan, and refunded in full if the clinician doesn't approve it or the patient cancels before a decision is made. The brand does note one exception worth flagging plainly: if a patient doesn't attend or reschedule the required video visit and abandons the intake, the deposit may be retained rather than refunded.

View current plan pricing and provider-care details

Pallas Health NAD+ Pricing: What You Actually Pay

As of the August 2026 live checkout page reviewed for this article, here's what Pallas Health charges for each format:

• Nasal spray: $79 for the first month, then $567 every 12 weeks - the brand presents this as averaging $189 a month.

• Injection: $89 for the first month, then $597 every 12 weeks - averaging $199 a month.

• Both plans include: the clinician review, ongoing check-ins, care-team messaging, and the medication itself when prescribed, with no separate membership fee.

• Billing: auto-renewing subscription, processed through Stripe, cancel anytime.

• Payment methods: cash-pay only, not billed to insurance; the site displays an "FSA & HSA eligible" badge.

The brand states the price "never increases" for a given plan. It also discloses elsewhere in its Terms of Service that subscription prices can change with at least 30 days' notice, taking effect at the start of the next billing cycle. Those two statements aren't necessarily contradictory - the marketing claim likely refers to your specific locked-in rate absent a policy change. But buyers relying on a promise that price will literally never move under any circumstance should confirm that directly with Pallas Health, since the Terms of Service reserves the right to change prices with notice.

The brand states plainly it does not store cardholder data. The "FSA & HSA eligible" badge is a claim about payment-method compatibility, not a guarantee that any specific administrator will reimburse a given purchase - insurance and benefit-account coverage, if any, depends on your specific plan and isn't independently confirmed by this article.

What Members Say About the Pallas Health Experience

Pallas Health's site publishes five named testimonials (first name and last initial, described by the brand as "Verified member"), describing themes around the general service experience rather than specific NAD+ treatment outcomes:

• The intake process felt straightforward and fast, with a same-day clinician follow-up in one account

• Shipping arrived quickly and discreetly, in plain packaging

• The care team responded to messages, described by one reviewer as replying "within hours"

• Members felt their provider explained options rather than rushing the decision

The brand's own disclaimer on that section states these are quotes from Pallas members describing their care experience, shared with permission, and explicitly notes that "testimonials reflect individual service experiences, not treatment outcomes." That's a meaningfully accurate distinction worth preserving here rather than blurring - none of the published quotes claim a specific NAD+ health benefit, and this article isn't characterizing them as if they did. Beyond the brand's own description of these as "verified," no independent third-party review platform, rating, or review count was identified in the sources reviewed for this article. Treat these as brand-published testimonials about service quality, not as independently audited product reviews.

Read more about how the Pallas Health process works

The Pallas Health Refund and Cancellation Policy

Pallas Health's Terms of Service, last updated July 11, 2026 as reviewed for this article, lay out a policy with a few distinct scenarios rather than one blanket rule, and the differences matter:

• If a clinician declines to prescribe, or an order otherwise isn't fulfilled and shipped: the brand states the payment is refunded in full, including any visit deposit collected under the charge-on-approval checkout flow described above.

• If you cancel: cancellation itself is described as free and available anytime through account settings or by contacting the brand, taking effect at the end of the current billing period. If a payment you already made qualifies for a refund - the brand's example is a medication payment made before the pharmacy has been asked to fill the order - the brand states the refund is issued for the amount paid minus third-party payment-processing costs and a $5 processing fee per refunded payment. This deduction never applies to clinician-declined or unfulfilled orders, only to voluntary cancellations of payments that hadn't yet gone to fulfillment, and it applies to purchases made on or after July 14, 2026, with earlier purchases refunded under whatever policy was in effect at the time of purchase.

• Once medication has been dispensed and shipped: the brand states the order cannot be returned or refunded, except where required by applicable law. This is a meaningfully different guarantee structure than a typical 60-day or 90-day money-back guarantee seen on many supplement products - the refund protection here centers on the clinical decision and pre-fulfillment cancellation window, not on a post-shipment satisfaction guarantee.

Is the Pallas Health NAD+ Program Right for You?

Pallas Health states that appropriateness is ultimately a clinical decision, made by a licensed provider after reviewing your health history - not something this article or any marketing page can determine for you. What this article can settle is the part that's actually yours to decide: does the structure fit what you're looking for?

• A subscription, not a one-time purchase - averaging $189-$199 a month after the first month, with your clinician built into that price rather than billed separately.

• A prescription pathway, not a self-directed purchase - a clinician reviews your case before anything ships, and can decide it isn't appropriate for you.

• Cash-pay, not insurance-billed - no claims, no prior authorization, no waiting on a carrier.

• Your choice of format - daily nasal spray or weekly injection, decided at intake.

If that's the kind of setup you were hoping to find when you clicked the ad, the intake is the fastest way to find out where you actually stand - a licensed clinician reviews your case, and you're not charged for medication unless they prescribe it. If what you actually want is a one-time purchase, an over-the-counter precursor supplement instead of a prescribed nasal spray or injection, or a guaranteed outcome, this program's structure isn't built for that, and no amount of marketing changes that fact.

Compare the nasal spray and injection plans directly

Things Worth Verifying Before You Start

Nothing below is a red flag in the sense of dishonesty - it's a short list of specifics the brand doesn't fully spell out on the pages reviewed for this article. For the deeper documentation gaps (the Terms of Service wording, physician credential specifics, review-platform data), see the companion coverage linked above.

• Exact dosing and compounding formulation. The brand does not publish the specific NAD+ concentration or per-dose amount for either the nasal spray or the injection. If the exact dose matters to your format decision, ask before you pay the first month's charge.

• Your state's synchronous-visit requirement. Eight jurisdictions (Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, and D.C.) currently require a live video visit before prescribing, per the brand's own disclosures. Confirm which category your state falls into, since it affects the $60 deposit mechanic described earlier.

• Price-change language. The brand advertises a rate that "never increases" for a given plan on its checkout page, while its Terms of Service separately reserves the right to change subscription prices with 30 days' notice. Ask Pallas Health directly how those two statements reconcile for your specific plan.

Review current program information and eligibility

NAD+ Nasal Spray vs. Injection vs. IV Therapy vs. Oral NMN: How the Delivery Methods Compare

If you've researched NAD+ at all, you've likely run into four different delivery methods, and it's easy to lose track of which is which. Here's how they line up, based on general research context rather than any single brand's marketing:

• IV infusion - the traditional method offered by longevity clinics and med spas, delivered directly into the bloodstream during an in-person session. This is the route most closely studied in the small tolerability research that exists on direct NAD+ administration, including the 2026 Reyna et al. pilot referenced above - but it requires an in-person visit, which neither of Pallas Health's two formats does.

• Subcutaneous injection - one of Pallas Health's two formats. Self-administered at home on a weekly schedule after clinician approval, rather than requiring a clinic visit.

• Intranasal spray - Pallas Health's other format. No needles, used daily as part of a routine.

• Oral NMN or NR (precursor supplements) - not what Pallas Health prescribes, but the category most other NAD+ products on the market actually are. These are typically sold over the counter as supplements rather than prescriptions, and they carry the largest body of published clinical trial research of any NAD+-related product category, per the 2025 Geromedicine systematic review cited above - though that research is about the precursor compounds themselves, not about Pallas Health's direct-NAD+ nasal spray or injection.

The practical takeaway: Pallas Health sits in the "direct NAD+, no clinic visit required" category, which trades the deeper research base of oral precursors for delivery convenience, and trades the traditional IV route's in-person setting for an at-home format. Neither trade-off is inherently better - it depends on what you're optimizing for.

How to Decide Between the Nasal Spray and the Injection

Since a clinician makes the final call on whether either format is appropriate for you, this isn't a decision this article can make for you. But the two options are priced within $10 of each other on the first month and $10 a month apart on the ongoing rate, so cost alone won't do much to break the tie. A few practical factors are more likely to:

• Needle comfort. The nasal spray involves no needles at all. The injection is a weekly subcutaneous shot, self-administered at home. If needle aversion is a factor for you, that alone may settle it.

• Routine fit. The spray is a daily habit; the injection is a once-a-week task. Some people find a daily routine easier to keep consistent, since it becomes automatic. Others prefer handling something once and not thinking about it again for a week.

• Travel and storage. Neither format's storage or travel requirements are detailed on the pages reviewed for this article - worth asking directly if you travel frequently or want to know before your first shipment arrives.

• Onset and absorption. The general research on NAD+ delivery routes (covered above) doesn't include a head-to-head comparison of intranasal versus subcutaneous administration specifically, so this article can't tell you which one the evidence favors - that's a fair question to put directly to your assigned clinician, who'll have more specific guidance than a general research summary can offer.

If none of that settles it for you, the brand's own intake asks for a preference and lets a clinician confirm it's appropriate - you're not locked into a guess.

See current Pallas Health NAD+ delivery options

What's Already Been Documented About Pallas Health's Structure and Terms

This article focuses on helping you choose between the nasal spray and the injection and understand what either one actually costs. It isn't trying to re-do the full verification workup on Pallas Health's operating structure. That groundwork has already been covered in detail elsewhere, including a companion breakdown of Pallas Health's three-entity structure, its named medical leadership's credentials cross-checked against the federal provider registry, and a documented gap between the wording of Pallas's Terms of Service and its live NAD+ program pages. That's worth reading if the operating structure and fine print matter more to your decision than the format choice does.

What's worth repeating briefly here: Pallas Health is the technology platform, Lion MD is the independent medical group whose clinicians make the actual prescribing decision, and one of six named pharmacies dispenses the medication once approved. The brand also displays a "LegitScript Healthcare Merchant Certified" badge, independently checkable through LegitScript's own verification tool.

Fast Facts About the Pallas Health NAD+ Program

• Operating company: Brentmoor, Inc.

• Governing law: State of Delaware, per the Terms of Service

• Business address: 131 Continental Dr, Suite 305, Newark, DE 19713

• Prescribing medical group: Lion MD, in partnership with CareValidate

• Named medical leadership: Dr. Ana Lisa Carr, MD (NPI 1689841744); Dr. Kelly Tenbrink, MD (NPI 1346482684)

• Delivery formats: daily nasal spray or weekly subcutaneous injection

• Nasal spray price: $79 first month, then $567 every 12 weeks (~$189/mo average)

• Injection price: $89 first month, then $597 every 12 weeks (~$199/mo average)

• Billing: auto-renewing subscription, cancel anytime, processed via Stripe

• Insurance: cash-pay only; not billed to insurance

• FSA/HSA: brand states plans are eligible; confirm with your specific administrator

• States served: all 50 US states plus Washington, D.C., per the brand

• States requiring a live video visit first: AR, MS, NM, ND, RI, SD, WV, and D.C.

• Visit deposit (where applicable): $60, credited toward first order or refunded if not approved

• Shipping: free, discreet, roughly one week per the brand

• Dispensing pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills Pharmacy (assignment varies)

• FDA status of compounded medication: not FDA-approved; not evaluated by FDA for safety, efficacy, or quality

• Refund if not approved or unfulfilled: full refund, per the brand's Terms of Service

• Refund if you cancel a pending payment: amount paid minus processing costs and a $5 fee, for purchases on or after July 14, 2026

• Once shipped: not returnable or refundable except as required by law

Quick Answers

Check current pricing and plan details

Is Pallas Health's NAD+ program FDA-approved? No. The compounded NAD+ medications Pallas Health's clinicians may prescribe are not FDA-approved products and have not been evaluated by the FDA for safety, efficacy, or quality, according to the brand's own clinical disclosures and Terms of Service reviewed for this article.

Does insurance cover the Pallas Health NAD+ program? No. According to the brand, the program is cash-pay only and is not billed to insurance. The site states plans are FSA/HSA eligible, which is a separate claim from insurance billing and should be confirmed with your specific plan administrator.

Who actually writes the prescription at Pallas Health? An independent, US-licensed clinician affiliated with Lion MD, the medical group Pallas Health's platform works with - not Pallas Health itself, which the brand states does not employ providers or practice medicine.

What happens if a Pallas Health clinician won't prescribe NAD+ for me? According to the brand's Terms of Service, if a licensed clinician does not approve a prescription, your payment - including any visit deposit - is refunded in full, and the order is not fulfilled or shipped.

Frequently Asked Questions

What is NAD+, according to Pallas Health?

Pallas Health describes NAD+ (nicotinamide adenine dinucleotide) as a coenzyme present in all of the body's cells that supports energy metabolism and normal cellular processes, with levels that tend to decline with age. That is the brand's own framing; this article does not independently verify a specific rate of decline or a guaranteed benefit from supplementation, and separately, per PubMed-indexed research, the extent of age-related NAD+ decline in humans specifically remains an active area of study rather than a settled fact.

Do I have to get injections to use the Pallas Health NAD+ program?

No. Per the brand, NAD+ is available as either a daily nasal spray, which involves no needles, or a weekly subcutaneous injection. You select a preference during intake, and a licensed clinician confirms whether that form is clinically appropriate for you and personalizes your dosing. The brand does not publish the exact per-dose concentration for either format on the pages reviewed for this article, so if the specific dosing matters to your decision, that's a reasonable question to raise directly with your clinician before your first payment.

How much does the Pallas Health NAD+ program cost?

As of the checkout page reviewed for this article, the nasal spray is $79 for the first month, then $567 every 12 weeks (about $189 a month on average). The injection is $89 for the first month, then $597 every 12 weeks (about $199 a month on average). Both prices are stated to be all-in, covering the clinician, ongoing check-ins, care-team messaging, and medication when prescribed.

Is Pallas Health's compounded NAD+ FDA-approved?

No. Pallas Health's own NAD+ program page states that Pallas does not manufacture or compound medication, and that compounded medications are prepared by US-licensed compounding pharmacies. That language, per the brand's site-wide disclosures, carries the standard compounded-medication caveat: not FDA-approved, and not evaluated by the FDA for safety, effectiveness, or quality. This article does not independently classify the product beyond what the brand itself discloses. Separately, the brand's Terms of Service note that 503B outsourcing facilities used by some of its partner pharmacies are registered with and inspected by the FDA under current Good Manufacturing Practice standards. But federal facility registration is not the same thing as FDA approval of the specific compounded medication you'd receive.

Which is better: the nasal spray or the injection?

Neither is positioned by the brand as clinically superior. The choice comes down to your own preferences and what a clinician confirms is appropriate for you. Cost is nearly identical between the two - $10 apart in both the first-month and ongoing price. So the deciding factors tend to be needle comfort, whether you'd rather manage a daily habit or a weekly task, and any input your assigned clinician gives once they've reviewed your health history. See the delivery-method comparison and decision-factor sections above for a fuller breakdown.

What pharmacy fills a Pallas Health NAD+ prescription?

One of six named partner pharmacies - Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, or Foothills Pharmacy - depending on the medication prescribed, the patient's shipping state, and current capacity, according to the brand's clinical disclosures page. You generally won't know which specific pharmacy fills your order until after a clinician approves your prescription.

Does Pallas Health require a video visit before prescribing?

It depends on your state. The brand states that Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, and Washington, D.C. currently require a synchronous audio/video visit before the patient-provider relationship is established. In other states, the brand states a clinician may evaluate and prescribe based on the intake questionnaire alone, requesting a video visit only if clinically warranted.

What is the $60 visit deposit some checkout flows show?

In states requiring a live video visit, checkout may collect a $60 deposit instead of the full first payment. According to the brand, the deposit is credited toward your first order if a clinician approves your plan after the visit, and refunded in full if the clinician doesn't approve it or you cancel before a clinical decision is made. The brand notes the deposit may be retained if you don't attend or reschedule the required visit and abandon your intake.

See current NAD+ program pricing and terms

Can I cancel the Pallas Health NAD+ subscription anytime?

According to the Terms of Service, yes - cancellation is described as free and available anytime through account settings or by contacting the brand, taking effect at the end of the current billing period rather than immediately. That's a distinct question from whether you get money back for a payment already made; the refund treatment of a canceled-but-already-paid order is addressed separately in the brand's refund terms and in the FAQ entry above on refunds after canceling.

What if I want a refund after canceling?

Per the brand's Terms of Service, if a payment you made qualifies for a refund - for example, a medication payment made before the pharmacy was asked to fill the order - the refund is the amount paid minus payment-processing costs and a $5 processing fee per refunded payment, for purchases made on or after July 14, 2026. This deduction doesn't apply if a clinician declined to prescribe or an order otherwise wasn't fulfilled. Those situations are refunded in full.

Can I get a refund after my NAD+ medication has shipped?

According to the Terms of Service, once medication has been dispensed and shipped, the order cannot be returned or refunded, except where required by applicable law. This is different from the clinician-decline refund and the pre-fulfillment cancellation refund described elsewhere in this article - both of those apply before a pharmacy ships anything, not after.

Does Pallas Health bill insurance for the NAD+ program?

No. The program is described as private pay only, with the brand explicitly stating it does not accept insurance for this program. The brand separately states plans are FSA/HSA eligible, which buyers should confirm with their specific plan administrator rather than assume applies universally, since FSA/HSA eligibility and traditional insurance billing are two different things governed by different rules.

Is Pallas Health's NAD+ program available in every state?

The brand states it currently accepts patients in all 50 states and Washington, D.C., with prescriptions written by a clinician individually licensed in the state where the patient is located at the time of the encounter. Some states carry additional requirements, most notably the synchronous video-visit rule described earlier, so "available" doesn't always mean an identical process everywhere.

How does Pallas Health's NAD+ program compare to over-the-counter NMN or NR supplements?

They're structurally different products. NMN and NR are oral precursor supplements sold without a prescription, and they carry the largest published clinical trial base of any NAD+-related category, per the research covered earlier in this article. Pallas Health's nasal spray and injection are prescription compounded medications, gated by a clinician's evaluation, with dosing personalized rather than fixed on a Supplement Facts panel. Neither this article nor Pallas Health's own materials claim the direct-NAD+ route outperforms oral precursors at an equivalent dose - they're different regulatory categories with different research bases, and the right one depends on whether you're looking for a prescribed, clinician-reviewed option or an over-the-counter one.

How is my health information protected?

Pallas Health states patient health information is handled under HIPAA - a published federal privacy framework. Medical records are created and maintained by the contracted clinical partner network, described by the brand as the HIPAA Covered Entity, with Pallas Health (Brentmoor, Inc.) acting as a HIPAA Business Associate under an executed agreement. This article does not independently audit the brand's HIPAA compliance program; it reports what the brand discloses about its structure.

Can I switch from the nasal spray to the injection later, or vice versa?

The pages reviewed for this article don't publish a specific policy on switching delivery formats mid-subscription. Given that ongoing care includes dose-adjustment visits and clinician follow-up, a format change seems like a reasonable thing to raise with your care team, but this article can't confirm the mechanics, timing, or any cost implications of doing so - ask directly before assuming it's a simple swap.

Does Pallas Health offer a discount code or coupon for NAD+?

No discount code, coupon, or promotional pricing beyond the standard first-month rate was identified on the pages reviewed for this article. If a specific promotion has been advertised to you elsewhere, confirm it directly with Pallas Health before assuming it applies at checkout - pricing shown here reflects the standard rate as of August 2026.

Are there complaints about Pallas Health's NAD+ program?

The companion piece linked earlier in this article ran a search of Trustpilot and the Better Business Bureau and didn't locate a dedicated review profile for the company - meaning no aggregated complaint pattern was found, but also that no independent complaint data exists to review either way. The five testimonials published on Pallas Health's own site are positive by nature of being brand-selected, so they aren't a source for complaint patterns. If a documented complaint history matters to your decision, check directly with the Better Business Bureau or a similar platform at the time you're reading this, since search results change.

Is Pallas Health legit?

The operating entity, its named medical group, and its named partner pharmacies are all disclosed on Pallas Health's own clinical disclosures page, and the brand displays a LegitScript Healthcare Merchant Certified badge that's independently checkable. A fuller legitimacy workup - including cross-checking named clinicians' credentials against the federal provider registry - is covered in the companion piece linked earlier in this article.

Buyer Verification Checklist

Start reviewing your eligibility options

1. Confirm your state of residence appears on Pallas Health's current list of served states, and check whether it's one of the eight jurisdictions requiring a synchronous video visit before prescribing.

2. Decide which delivery format you're interested in - daily nasal spray or weekly injection - and note that final dosing is determined during the clinical intake, not published in advance.

3. Confirm current pricing for your chosen format directly on the official checkout page, since figures in this article reflect a specific point-in-time review.

4. Ask directly which of the six partner pharmacies is likely to fill your prescription if that matters to you.

5. If you're in a state requiring a video visit, confirm the $60 deposit mechanic and calendar the visit - don't miss or reschedule past the point where the deposit becomes non-refundable.

6. Read the cancellation and refund terms in full on the brand's Terms of Service page before your first payment, particularly the distinction between a clinician-decline refund (full) and a voluntary-cancellation refund (minus fees, and only before fulfillment).

7. If FSA/HSA eligibility affects your decision, confirm directly with your plan administrator rather than relying solely on the brand's badge.

8. Verify the named clinicians' credentials directly through the federal NPPES NPI Registry if that verification matters to you before starting intake.

Review current pricing and eligibility details

The Bottom Line

Pallas Health publicly describes a telehealth structure involving its own technology platform, independent clinicians affiliated with Lion MD, and a group of named, US-licensed dispensing pharmacies. Its current NAD+ program page publishes first-month and renewal pricing for both delivery formats, and its Terms of Service state that patients are refunded in full if a clinician decides treatment isn't appropriate, or if an order otherwise isn't fulfilled and shipped. Those specifics - the entity structure, the pricing, the non-approval refund - are documented on the brand's own pages and reflected accurately in this article.

What isn't established is clinical efficacy for Pallas Health's specific compounded nasal spray or injection. The brand doesn't claim finished-product trial data, and this article hasn't implied any either - the research base for NAD+ sits mostly at the level of general cellular biology and oral precursor-supplement trials, not a study of this exact formulation. No clinical trial of Pallas Health's own NAD+ product was identified in the sources reviewed for this article.

So here's where that leaves you. If what you're after is a doctor-supervised, transparently priced path to prescription NAD+ - one where a licensed clinician actually reviews your case, and you're not out any money if they say no - this article has laid out exactly how that path works, format by format, dollar by dollar. The intake takes about two minutes, and it's the only way to find out where you actually stand. If what you're after is proof of a specific health outcome, that's a separate question no article can answer for you - ask the prescribing clinician directly, before you decide, not after.

Pallas Health NAD+ Contact Information

General support:

• Email: hello@pallashealth.co

• Phone: +1 (440) 601-3717, Monday through Friday, 9 AM to 5 PM Eastern

• Compliance, licensure-verification, and LegitScript inquiries: support@pallashealth.co

• Business address: 131 Continental Dr, Suite 305, Newark, DE 19713

• Operating entity: Brentmoor, Inc.

• Official program page: pallashealth.co/lp/nad

Learn more about the Pallas Health NAD+ program

Lander Phrase Glossary

• "Clinician-prescribed." Brand phrase describing that a US-licensed clinician affiliated with Lion MD reviews each patient's intake and makes an independent prescribing decision. It does not mean every applicant is approved - approval is not guaranteed.

• "One price." Brand phrase referring to the all-in monthly or 12-week charge that the brand states covers provider care, check-ins, messaging, and medication together, without a separate membership fee. It does not mean the price is contractually frozen forever; the Terms of Service reserves the right to change subscription prices with 30 days' notice.

• "FSA & HSA eligible." Brand-stated claim that the service is compatible with flexible spending and health savings account payment methods. It is not a guarantee of reimbursement by any specific plan administrator - confirm with your own FSA/HSA administrator before assuming reimbursement.

• "LegitScript Healthcare Merchant Certified." A third-party merchant certification the brand displays and links out to verify directly on LegitScript's site. This article references the brand's own link to that verification tool rather than independently re-confirming certification status at the moment you're reading this.

Disclosure and Compliance Information

Material Limitations: This article was built from Pallas Health's official checkout page, clinical disclosures page, and Terms of Service, all fetched live in August 2026, plus general NAD+ research located through PubMed-indexed sources. No product was independently tested, and no clinician, pharmacy, or Pallas Health representative was independently interviewed for this article. Brand claims - including pricing, refund mechanics, medical-group and pharmacy relationships, and testimonial content - are not independently verified beyond what the brand itself discloses on its public pages, and title phrases referencing brand language are brand-originated, not this publication's own characterization. Facts that could not be confirmed from a live source, a physical document, a verified third-party listing, or direct client confirmation were omitted rather than assumed; the exact NAD+ dose per spray or injection is one such omitted specific, since it is not published on the pages reviewed. Contact the brand directly to verify any material claim before purchasing.

Third-Party Feedback Platforms: The accuracy of third-party review platforms, ratings, or feedback tools referenced or linked from this article or the brand's own site is not endorsed by this publication. Readers should evaluate any such platform critically and independently.

Forward-Looking Statements: This article reflects information gathered in August 2026. Pricing, program structure, clinical partners, dispensing pharmacies, state availability, and policies described here may change after publication. Readers should rely on Pallas Health's official site for current information rather than treating this article as a live source.

Marketing Language Notice: Attribution language throughout this article identifies statements as brand claims. Body phrases drawn from Pallas Health's own marketing - including "clinician-prescribed," "one price," and similar language - are brand-asserted marketing language, not independent rankings, lab-verified claims, or this publication's own conclusions.

California Proposition 65 Notice: No Proposition 65 warning was identified in the sources reviewed for this article. Because this program involves a compounded medication rather than a standardized retail product, buyers in California with Proposition 65 questions should confirm directly with Pallas Health and the dispensing pharmacy assigned to their prescription.

Geographic and Jurisdiction Notice: This article addresses the Pallas Health NAD+ program as offered to US residents in states where the brand states the service is currently available. Nothing in this article should be read as an offer or solicitation in any jurisdiction where the underlying telehealth or compounded-pharmacy service is not authorized.

Trademark Acknowledgment: Pallas Health and any associated logos are trademarks or service marks of their respective owner as referenced on the brand's official site; no independent trademark registration search was performed for this article, and no registration symbol is used absent brand confirmation. Lion MD, CareValidate, Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills Pharmacy, and any other third-party names referenced are the property of their respective owners and are named here solely to describe their disclosed role in the Pallas Health program.

FTC Material Connection Disclosure: As stated at the top of this article, a commission is earned if a purchase is made through affiliate links in this content. This relationship is disclosed in accordance with FTC guidance on material connections in advertising and endorsements.

SOURCE: Pallas Health

Source: Pallas Health